Search

everythinglearnresearchcommunity

for

Search:↓

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Older people at home often have skin issues, but there's little evidence on how to prevent or treat them effectively.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Beetroot extract may help treat hair loss naturally with fewer side effects.

Scalp cooling effectively prevents hair loss during chemotherapy in most cases.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Corticosteroid injections helped eyebrow hair regrow in men with alopecia areata.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

5% minoxidil significantly increases hair follicle density.